The company has built a global level of bio-pharmaceutical research and development and industrialization platform; established for cancer, autoimmune diseases, inflammation and cardiovascular disease of the rich product line. The scale of the company's platform, hardware and software facilities, the number of new drug product lines, R & D team in the country are the same industry-leading level. Kang Fang biological has been with the international and domestic listed pharmaceutical companies to establish a cooperative relationship, the joint development of innovative antibodies to new drugs, is a strategic cooperation in the form of development of new drugs in the forerunner.

Dongda Biotechnology (Suzhou) Co., Ltd., established on 2017-02-28, Business scope includes research and development of biological products and biotechnology,technical consulting,Technology Transfer and Technical Services;Corporate management services for biotechnology and pharmaceutical projects.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hanhai Boxing is a biotech company that develops anti-cancer drug PD1 monoclonal antibodies that can treat a variety of solid tumors. Compared with similar products on the market or in clinical trials, this product has the advantages of high purity, high affinity, low cost, independent intellectual property rights, etc. The annual sales revenue of the product is expected to reach billions of dollars after the product is launched. The company has successively won the "National High-tech Enterprise", "Hewu Clam Major Talent and Achievement Project", "National Genetic Testing Application Demonstration Center", "International R&D Service Outsourcing Innovation Platform", "Hefei Intellectual Property Demonstration Enterprise", "Anhui Province" AAAA-level credit enterprise", "A-level contract and trustworthy enterprise" and many other honors. The company has been reported by many well-known media such as CCTV-1 News Network, Anhui Satellite TV News Network, China Daily, People's Daily, and Guangming Daily.

Sichuan Kelun Botai Biomedical Co., Ltd., established on 2016-11-22, Business scope includes biopharmaceuticals,Chemical Raw Materials,Research and development of chemical preparations,production and sales;Import and export,Technology Import and Export;Technical extension services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Kangfang Pharmaceutical Co., Ltd., established on 2017-08-10, Business scope includes medical research and experimental development;R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product sales(No licensed chemical products);pharmaceutical production;Drug Wholesale;Drug import and export;Import and export;Technology Import and Export

CP Tianqing Kangfang (Shanghai) Biomedical Technology Co., Ltd., established on 2019-08-30, The scope of business includes engaging in biomedicine(In addition to biological reagents)Technology development in the field of product and professional technology,technology transfer,technical consulting,Technical Services;Expo Services. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Anyuan Pharmaceutical Technology (Shanghai) Co., Ltd. is a Chinese private company located in Shanghai. The firm develops biological macromolecular drugs. It was founded in 2016. Qiang Li is currently the CEO of the company.

Beijing Institute of Collaborative Innovation is a Chinese private company. The firm operates as a venture capital firm.

Nanjing Genscript Co., Ltd. provides biological and pharmaceutical research services. It offers gene, peptide, protein production and purification, and antibody outsourcing services. The company was founded in 2004 and is headquartered in Nanjing, China.

Innolake Pharmaceuticals (Hangzhou) Co., Ltd. is a company headquartered in Hangzhou, China, that engages in development and commercialization of therapeutic drugs for tumors & immune system diseases. It was founded in 2020 by Ru Lei Chen and Ming De Xia. Ming De Xia has been the CEO since that date.

ExcelMab develops a series of anti-tumor bispecific antibody drugs for cancer patients.

Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China.

Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline include daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma; teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease; and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998 and is headquartered in Copenhagen, Denmark.

Wuhan Baiyingnuo Biotechnology Co., Ltd., established on 2021-06-28, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class II Medical Devices;Class II Medical Device Leasing;Sales of Class I Medical Devices;Production of Class I Medical Devices;Class I Medical Device Leasing;Specialty Chemicals Sales(Free of Hazardous Chemicals);Special Equipment Repair;Health Consulting Services(Does not include medical services);Glassware Sales;Drug testing equipment sales;Instrument sales;Experimental analysis instrument sales;Mechanical Parts,Parts sales;Import and export;Technology Import and Export;Import and export agency(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of Class II Medical Devices;Class III medical device business;Class III Medical Device Leasing;Production of Class III Medical Devices;Inspection and testing service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Zhongshan Kangfang Innovative Medicine Research Institute Co., Ltd., established on 2016-07-18, The scope of business includes engaging in diagnostic reagents,protein research and development(National Prohibition,Except for the management of restricted categories and special regulations),Achievement Transformation,Technical extension services,Technical Advisory Services,Investment,Conference Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Youfeng (Beijing) Biotechnology Co., Ltd., established on 2020-12-16, Business scope includes biotechnology,Bioengineering technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Technical Services;Import and export,Technology Import and Export;Sales of medical devices Class I,Class II;wholesale medicine;retail medicine;Sales of Class III Medical Devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;wholesale medicine,retail medicine,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Banju Biotechnology Co., Ltd., established on 2017-07-14, Business scope includes biological,Technology development in the field of agriculture,technology transfer,technical consulting,Technical Services,Technology Promotion;crop farming(Free of Wild Plants,seed,aloe vera,Narcotic drug original plant,turf);property management;Agricultural Science Research and Experimental Development;Economic and Trade Consulting;business management;Business Management Consulting;Sales of daily necessities,stationery,wooden product,paper products,plastic products,flowers,Edible produce,cosmetic,Ikind,Class II medical device;sell food;Sales of Class III medical devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;sell food,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Mylan Laboratories Ltd. manufactures and supplies active pharmaceutical ingredients. The firm operates through two segments: Pharmaceuticals and Medical Supplies. It manufactures and supplies generic and branded generic formulations to various markets, including North America, Europe and Asia Pacific. Mylan Laboratories was founded on November 29, 1984 and is headquartered in Hyderabad, India.

Shandong Jianmu Biological Pharmaceutical Co., Ltd., established on 2002-03-29, Business scope includes powder/Premix,Terminally sterilized small volume injection,Powder,oral solution,tablet/Granules,disinfectant(liquid)production;Microbial Additives(II):Bacillus subtilis production;Additive premix feed production(The validity period of the above items is subject to the license);feed production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).